NIH-funded research Fellowship grant

Genetic factors influence T cell behavior in Type 1 Diabetes

Official title: HLA risk alleles cause Type 1 Diabetes by modifying the selection of T cell receptors that recognize pancreatic beta cell antigens

Funded at Harvard Medical School · NIH-11075762 · Data updated 2026-11-12

This study is looking at how certain genes might influence the way our immune cells, called T cells, attack insulin-producing cells in people with Type 1 Diabetes, helping us understand why some people get the disease while others with similar immune cells do not.

Quick facts

Grant typeFellowship grant
Study typeNIH-funded research
Funding institutionHarvard Medical School
NIH-funded
Lab location1 site (Boston, United States)
Project startJanuary 1, 2024
Project endDecember 31, 2026
Funding year2025
Award (this year)$53,974
NIH project number5F30AI176724-02
Project IDNIH-11075762 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals with a family history of Type 1 Diabetes or those who have been identified as having HLA risk alleles.

Less likely to help

Patients who do not have any genetic predisposition to Type 1 Diabetes or those who are already diagnosed with advanced stages of the disease may not benefit from this research.

What this research studies

This research investigates how specific genetic variations, known as HLA risk alleles, affect the selection of T cell receptors that target pancreatic beta cells in individuals with Type 1 Diabetes (T1D). By understanding the relationship between these genetic factors and T cell behavior, the research aims to uncover why some individuals develop T1D while others do not, despite having similar T cell receptors. The approach involves analyzing T cell receptor sequences and their functional potential in relation to T1D risk. This could lead to new insights into the autoimmune processes that drive the disease.

Why it matters

Potential benefit: If successful, this research could lead to improved strategies for preventing or treating Type 1 Diabetes by targeting the underlying genetic factors.

How similar studies have gone: Previous research has shown promising results in understanding the genetic basis of autoimmune diseases, suggesting that this approach could yield valuable insights.

Where this research is happening

  • Harvard Medical School
    Boston, United States
    Active

Researchers

  • Principal investigator: Lagattuta, Kaitlyn Anne — Harvard Medical School
  • Study coordinator: Lagattuta, Kaitlyn Anne

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.